Dr. Ali Mahmoud Ghazzawi

Dr. Ali Mahmoud Ghazzawi is a Specialist Medical Oncologist at Burjeel Royal Hospital in Al Ain with over 7 years of clinical experience treating cancer patients. He holds an MD from Damascus University, the Syrian Board Certification in Medical Oncology, and a Master's Degree in Medical Oncology. His training spans internal medicine, emergency medicine, and intensive care at leading Syrian hospitals (Al-Assad and Al-Mouasat University Hospitals, 2013–2015), followed by specialized oncology training at Al-Bairouni University Hospital (2015–2018). He has also served as Head of the Department of Medical Oncology at a Canadian hospital in Dubai.

Dr. Ghazzawi's clinical focus covers breast, thoracic (lung), and colorectal cancers, along with oncologic emergencies, cancer screening, and treatment planning. He has extensive experience diagnosing, screening, and implementing treatment protocols for various cancer types. His research interests include breast cancer efficacy studies, including published work on capecitabine as second-line treatment for metastatic breast cancer (2023).

Fluent in English and Arabic, Dr. Ghazzawi is well-suited for patients seeking specialist cancer care with a particular emphasis on breast and lung malignancies, as well as those requiring urgent oncologic emergency management.